Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 2 of 2 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Maximum Tolerated Dose of CEP-37440 in Patients With Advanced or Metastatic Solid Tumors
- Condition(s):
- Solid Tumors
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: CEP-37440
PD, PK, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
- Condition(s):
- Solid Tumors
- Status:
- Withdrawn
- Requirements:
- 2 Years to 17 Years
- Interventions:
- Drug: Balugrastim | Drug: Filgrastim